Lets do some number crunching.
There are 5,759 Hospitals in the United States. I am only looking at the US for this exercise.
Lets make the assumption that in the next 2 or 3 years Medizone can only get ONE Asepticsure machine into only 20% of the Hospitals.
Sales price .................................................$125,000
1/5 of 5,759 = ............................................1,152
Multiply yields.............................................$144,000,000 (rounded up)
Shares outstanding = 330 Million
Total value of MZEI ........................................44 cents per share
At a PE ratio of 10 .........................................$4.40 per share
This assumes EPA approval and Medizone capable of making these sales.
I will leave you with these thoughts:
1) Assuming I am 80% wrong we still could get to 88 cents per share, instead of $4.40
2) Assuming all 5,759 hospitals buy 1 unit we get to $2.18 per share (or with PE of 10), $21.80 per share
3) Now assume Each hospital buys 2 machines: $43.60 per share
4) Now consider sales in Canada, India, United Kingdom, Singapore...........
5) Now consider miniaturization for cruise ships..........
6) Now consider Bed Bugs..................
So why are we still sitting at .14 ??? Is there still doubt about EPA approval?
I DON'T THINK SO !
